Are you Dr. McHutchison?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-620-4467
Summary
- Dr. John McHutchison, MD is a gastroenterologist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina and California. He is affiliated with Duke University Hospital.
Education & Training
University of Melbourne Faculty of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1991 - 2024
NC State Medical License 2002 - 2024
Clinical Trials
- Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection Start of enrollment: 2007 Nov 01
Publications & Presentations
PubMed
- ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer.Zhenwei Peng, Guangyan Wei, Pinzhu Huang, Heansika Matta, Wen Gao
Hepatology. 2024-08-01 - 50 citationsEvaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.Behzad Hajarizadeh, Jason Grebely, Marianne Byrne, P. Marks, Janaki Amin
The Lancet. Gastroenterology & Hepatology. 2021-07-01 - 219 citationsThe Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl
Hepatology. 2019-12-01
Press Mentions
Nobel Laureate Dr. Michael Houghton Appointed to Assembly Biosciences Board of DirectorsJuly 20th, 2021- Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and ManufacturingNovember 17th, 2020
- Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD the Liver Meeting Digital Experience™November 13th, 2020
- Join now to see all
